Guru Ownership Trend
Guru Analysis for PTC Therapeutics, Inc. (PTCT)
PTC Therapeutics, Inc. (PTCT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $279.55 M.
Top institutional holders include Jefferies Group and Steven Cohen.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $155.9 M net inflow during the quarter.
Recent activity highlights Chuck Royce who increased their stake by 146.5%. Conversely, John Hussman reduced exposure by 60.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2025)
Guru Consensus (Q3 2025)
FAQs for PTC Therapeutics, Inc. (PTCT)
Major holders include Jefferies Group ($125.98 M), Steven Cohen ($74.91 M), Renaissance Technologies ($46.15 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 3.95 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $155.9 M, with 3 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited PTCT. The total reported sell value was $16.99 M.
Yes, 3 managers opened new positions in PTCT, and 0 increased their existing holdings. The total reported buy value was $172.9 M.
